Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
20/20 Biolabs, Inc.
| Metric | 20/20 Biolabs, Inc. AIDXIndustrials |
|---|---|
| Quality Score | 51 / 100 |
| Revenue (latest) | $2M |
| Net income (latest) | −$4M |
| Operating margin | −162.9% |
| Net margin | −182.8% |
| Return on equity | 19447.7% |
| Return on assets | −90.4% |
| Return on capital (ROCE) | −199.0% |
| Debt / equity | — |
| Revenue growth (YoY) | 16.7% |
| Altman Z″ (distress) | -33.18 |
| Accruals / assets | −44.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.